A patient in their 70s starts getting breathless while walking to the market. At first, they blame age.
Then climbing one flight of stairs becomes difficult. The echocardiogram shows a serious valve problem, and the family hears something that sounds reassuring but confusing: “You may not need open-heart surgery.”
That is where procedures such as TAVR and MitraClip can enter the conversation.
As a cardiac care team serving patients around Sarita Vihar, Okhla, Sukhdev Vihar and South Delhi, we often meet families who know they need valve treatment but do not understand their options.
The important thing is this: TAVR and MitraClip are not interchangeable procedures. They treat different valve problems.
TAVR, or transcatheter aortic valve replacement, is a minimally invasive procedure used to replace a diseased aortic valve.
The aortic valve controls blood flow from the heart to the rest of the body. When it becomes severely narrowed, a condition called aortic stenosis, the heart has to work harder to push blood through the valve.
This can cause:
Breathlessness
Chest discomfort
Dizziness
Fainting
Fatigue
Reduced ability to exercise
TAVR allows a new valve to be delivered through a catheter, commonly through an artery in the groin, and positioned inside the diseased aortic valve.
It is different from traditional open-heart valve replacement.
MitraClip is a device used for a catheter-based treatment called transcatheter edge-to-edge repair, or TEER.
It is used for selected patients with significant mitral regurgitation, where the mitral valve does not close properly and blood leaks backward.
The MitraClip brings portions of the mitral valve leaflets together to reduce the amount of leakage.
It does not replace the valve in the same way TAVR replaces the aortic valve.
The simplest way to remember the difference is:
TAVR treats a diseased aortic valve.
MitraClip treats selected patients with significant mitral valve leakage.
Which procedure is appropriate depends on the valve involved, the severity of the disease, symptoms, anatomy, heart function and overall surgical risk.
You may need a specialist evaluation if you have been diagnosed with:
Severe aortic stenosis
Significant mitral regurgitation
Breathlessness without an obvious cause
Fainting associated with suspected valve disease
Chest discomfort related to exertion
Progressive fatigue or reduced exercise capacity
Heart failure associated with valve disease
A valve problem that your cardiologist says may require intervention
An echocardiogram is often central to evaluating valve disease.
However, one abnormal report does not automatically mean you need TAVR or MitraClip.
The specialist needs to understand the entire clinical picture.
Patients sometimes hear that TAVR or MitraClip is minimally invasive and assume it is almost risk-free.
That is not the right way to think about it.
These are sophisticated cardiac procedures performed through blood vessels or catheter-based access, but they still carry risks.
The right question is not, “Can I avoid surgery?”
It is:
“Which treatment offers the best balance of benefit and risk for my specific valve problem?”
Sometimes a surgical repair or replacement remains the better option. In other patients, a transcatheter approach may offer an important alternative.
TAVR is mainly considered for selected patients with significant aortic valve disease, particularly severe aortic stenosis.
Age, symptoms, surgical risk, anatomy, life expectancy, other medical conditions and patient preference can all influence the decision.
Modern valve care is becoming increasingly individualised rather than based on one simple rule.
A 2025 American Heart Association report highlighted a trial of more than 900 adults with asymptomatic severe aortic stenosis in which early TAVR reduced the combined risk of death, stroke or unplanned cardiovascular hospitalisation compared with clinical surveillance.
That does not mean every patient with severe aortic stenosis should immediately undergo TAVR.
It does show why timing and patient selection deserve a careful specialist discussion.
MitraClip may be considered for selected patients with significant mitral regurgitation who remain symptomatic despite appropriate treatment and who have suitable valve anatomy.
It can be particularly relevant when conventional surgery carries substantial risk.
For some patients with secondary mitral regurgitation linked to heart failure, guideline-directed heart-failure treatment is an important part of care before considering a transcatheter procedure.
The decision is therefore not simply based on how much leakage appears on an echocardiogram.
The patient's symptoms, heart function, anatomy and response to medical treatment all matter.
Consider an older patient with severe aortic stenosis who has gradually stopped going for morning walks because of breathlessness.
The family initially assumes this is normal ageing.
An echocardiogram identifies severe valve narrowing. A valve team then reviews the patient's age, heart function, other medical conditions and valve anatomy to determine whether TAVR or surgical valve replacement is more appropriate.
The important lesson is that the patient's symptoms and overall health matter just as much as the valve measurement itself.
Another patient may have significant mitral regurgitation but also have heart failure that has not yet received optimal medical treatment. In that situation, the first step may be to improve medical therapy before deciding whether MitraClip is appropriate.
The American Heart Association reported in 2025 that more than 28 million people worldwide were living with some form of heart valve disease, and more than 60,000 people die from heart valve disease each year in the United States.
That makes valve disease much more than an “old age” issue that can simply be ignored.
Early recognition matters because symptoms can gradually become part of everyday life, making patients underestimate how much their condition has changed.
A proper valve evaluation usually involves more than one test.
Your cardiology team may review:
Echocardiography
ECG
Blood tests
Heart function
Previous cardiac history
CT imaging when required
Kidney function
Other medical conditions
Previous surgeries or procedures
Valve procedures depend heavily on anatomy.
For TAVR, the team needs detailed information about the aortic valve, surrounding structures and blood vessels used for access.
For MitraClip, doctors need to determine whether the mitral valve anatomy is suitable for clip placement.
Advanced imaging and 3D echocardiography can play an important role in planning complex mitral procedures.
Do not choose a valve specialist only because they advertise the latest procedure.
Ask practical questions:
This sounds basic, but it determines whether TAVR, MitraClip, surgery or another treatment is even relevant.
Ask the doctor to explain the severity in plain language.
You should understand the expected benefit.
Surgery, medication, monitoring and transcatheter procedures may all have a role depending on the condition.
This is particularly important for catheter-based valve procedures.
Dr. Vivudh Pratap Singh is an interventional cardiologist associated with Fortis Okhla and the wider South Delhi region. His professional profile highlights experience in structural heart procedures, including TAVI and MitraClip, alongside complex coronary interventions. This combination can be relevant for patients requiring specialist evaluation of advanced valve disease and catheter-based treatment options.
TAVR replaces a diseased aortic valve using a catheter-based approach. MitraClip is a catheter-based repair technique used for selected patients with significant mitral regurgitation.
Selected patients with significant aortic stenosis may be considered for TAVR. Age, symptoms, valve anatomy, surgical risk, heart function and overall health all influence the decision.
Not necessarily. MitraClip can be valuable for carefully selected patients, particularly those who have significant mitral regurgitation and may face high surgical risk. The appropriate treatment depends on the patient's anatomy and clinical condition.
Valve disease can progress slowly, and patients sometimes adjust their lifestyle without realising that their heart condition is getting worse.
If you have been diagnosed with aortic stenosis or mitral regurgitation—or you have unexplained breathlessness, fainting or declining exercise capacity—get the condition properly evaluated.
If you are searching for a TAVR and MitraClip specialist in Sarita Vihar, bring your echocardiogram, previous cardiac reports and medication list to a specialist consultation.
Ask what valve is affected, how severe the problem is, whether you are suitable for a catheter-based procedure, and what alternatives are available. The right valve treatment starts with the right diagnosis.
| Tags: | #TAVR and MitraClip Specialist in Mahipalpur, # TAVR and MitraClip Specialist in Mehrauli , # TAVR and MitraClip Specialist in Katwaria Sarai, # TAVR and MitraClip Specialist in Ber Sarai |
